Vivos Therapeutics, Inc. (NASDAQ: VVOS) has expanded its partnership with Greenway Health to deploy Greenway's AI-enabled Novare platform across its clinical and revenue cycle operations, beginning with Sleep Centers of Nevada, according to a press release from the Littleton, Colorado-based company.

Greenway Health estimates that implementing its Novare platform at Sleep Centers of Nevada could generate approximately $9.1 million in potential annual value, including roughly $8.0 million attributed to increased patient capacity and $1.0 million from revenue cycle improvements. Vivos separately estimates potential savings of up to $1.8 million annually from the recovery of more than 46,000 employee hours per year, which the company says could create capacity for nearly 30,000 additional patient visits.

The Novare platform integrates clinical, revenue cycle, and patient engagement workflows and was built around agentic artificial intelligence rather than adding AI to existing legacy software. Capabilities are expected to include ambient AI note generation, automated insurance eligibility verification, prior-authorization automation, HCC and ICD coding assistance, and technology designed to reduce claim denials by up to 20%.

Vivos CEO Kirk Huntsman said the company plans to extend the Greenway deployment to planned locations in Arizona and Florida. "The tremendous leverage we expect to gain from optimizing the use of an AI-driven platform for our operations will result in faster revenue cycles and improved time to market in each new market we enter," Huntsman said.

Richard Atkin, CEO of Greenway Health, said the partnership is aimed at reducing administrative burdens and improving operational efficiencies across Vivos' ambulatory healthcare operations.

Greenway noted that its estimates were based on analysis of operational data from Sleep Centers of Nevada and that actual results will depend on implementation, patient demand, reimbursement conditions, and other factors. Vivos cautioned that forward-looking statements carry risks, including the possibility that anticipated savings and revenue benefits may not materialize.